A review of strategies for enhancing the completeness of notifiable disease reporting.

Notifiable disease surveillance systems provide essential data for infectious disease prevention and control programs at the local, state, and national levels. Given that reporting completeness is known to vary considerably, this review identifies methods that can reliably enhance completeness of reporting. These surveillance-related activities include initiating active surveillance when appropriate; implementing automated, electronic laboratory-based reporting; strengthening ties with clinicians and other key partners in notifiable disease reporting; and increasing the use of laboratory diagnostic tests in identifying new cases. Despite ample data in support of these strategies, notifiable disease surveillance continues to receive insufficient attention and resources. Recent attention to public health preparedness provides an opportunity to strengthen notifiable disease surveillance and enhance completeness of reporting.

[1]  J. Duchin,et al.  Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients with a Newly Recognized Disease , 1994 .

[2]  E. Lautenbach,et al.  Automated Laboratory Reporting of Infectious Diseases in a Climate of Bioterrorism , 2003, Emerging infectious diseases.

[3]  T. Jones,et al.  Limitations to successful investigation and reporting of foodborne outbreaks: an analysis of foodborne disease outbreaks in FoodNet catchment areas, 1998-1999. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Fannin,et al.  Improving disease reporting in Los Angeles County: trial and results. , 1988, Public health reports.

[5]  D. Murphy From expert data collectors to interventionists: changing the focus for infection control professionals. , 2002, American journal of infection control.

[6]  R. Haley,et al.  The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. , 1985, American journal of epidemiology.

[7]  J. Wells,et al.  Hamburger-associated Escherichia coli O157:H7 infection in Las Vegas: a hidden epidemic. , 1997, American journal of public health.

[8]  G. Istre,et al.  Is passive surveillance always insensitive? An evaluation of shigellosis surveillance in Oklahoma. , 1988, American journal of epidemiology.

[9]  J. Hughes,et al.  Disease Surveillance and the Academic, Clinical, and Public Health Communities , 2003, Emerging infectious diseases.

[10]  C. Bridges,et al.  Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Effler,et al.  Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. , 1999, JAMA.

[12]  J. Boyce Hospital epidemiology in smaller hospitals. , 1995 .

[13]  M. Osterholm,et al.  Impediments to public health surveillance in the 1990s: the lack of resources and the need for priorities. , 1996, Journal of public health management and practice : JPHMP.

[14]  Michael E. Bales,et al.  Planning against biological terrorism: lessons from outbreak investigations. , 2003, Emerging infectious diseases.

[15]  A. Reingold,et al.  If syndromic surveillance is the answer, what is the question? , 2003, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[16]  J M Hughes,et al.  Infectious disease surveillance: a crumbling foundation. , 1994, Science.

[17]  A. Fine,et al.  Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  I. Onorato,et al.  Completeness and timeliness of tuberculosis case reporting. A multistate study. , 2001, American journal of preventive medicine.

[19]  G. Birkhead,et al.  Assessment of surveillance for meningococcal disease in New York State, 1991. , 1996, American journal of epidemiology.

[20]  R. Pinner,et al.  Electronic laboratory-based reporting for public health. , 2000, Military medicine.

[21]  D. Koo,et al.  History and current status of the National Notifiable Diseases Surveillance System. , 1996, Journal of public health management and practice : JPHMP.

[22]  Michael M. Wagner,et al.  Automatic Electronic Laboratory-Based Reporting of Notifiable Infectious Diseases , 2002, Emerging infectious diseases.

[23]  R. Vogt,et al.  Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont. , 1983, American journal of public health.

[24]  D. Rose,et al.  The underreporting of disease and physicians' knowledge of reporting requirements. , 1984, Public health reports.

[25]  B. Swaminathan,et al.  PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. , 2001, Emerging infectious diseases.

[26]  J. Roehrig,et al.  The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. , 2000, Emerging infectious diseases.

[27]  S. Groseclose,et al.  Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. , 2002, American journal of epidemiology.

[28]  L. McCaig,et al.  Food-related illness and death in the United States. , 1999, Emerging infectious diseases.

[29]  J. Wells,et al.  A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. , 1994, JAMA.

[30]  Jeffrey P Koplan,et al.  Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. , 2002, JAMA.

[31]  S B Thacker,et al.  A controlled trial of disease surveillance strategies. , 1986, American journal of preventive medicine.

[32]  D. Sosin Syndromic surveillance: the case for skillful investment. , 2003, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[33]  D Koo,et al.  Mandatory reporting of diseases and conditions by health care professionals and laboratories. , 1999, JAMA.

[34]  L. Bush,et al.  Index case of fatal inhalational anthrax due to bioterrorism in the United States. , 2001, The New England journal of medicine.

[35]  W. Schaffner,et al.  Evaluation of innovative surveillance for drug-resistant Streptococcus pneumoniae. , 2001, American journal of epidemiology.

[36]  G. Rutherford,et al.  Public health, communicable diseases, and managed care: Will managed care improve or weaken communicable disease control? , 1998, American journal of preventive medicine.

[37]  W Schaffner,et al.  The reporting of communicable diseases: a controlled study of Neisseria meningitidis and Haemophilus influenzae infections. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  David M. Hartley,et al.  Syndromic Surveillance and Bioterrorism-related Epidemics , 2003, Emerging infectious diseases.

[39]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.